Catheter-directed thrombolysis appeared associated with a persistent risk reduction for post-thrombotic syndrome among patients with extensive proximal deep vein thrombosis, according to follow-up ...

Please provide your email address to receive an email when new articles are posted on . HOLLYWOOD, Fla. — Post-thrombotic syndrome remains a significant issue in patients with acute deep vein ...

In the treatment of patients with a high proximal deep vein thrombosis (DVT) and low risk of bleeding, catheter-directed thrombolysis should be considered in addition to conventional antithrombotic ...

While catheter-directed thrombolysis and anticoagulation for deep vein thrombosis (DVT) does not appear to increase mortality over standard anticoagulation alone, it leads to bleeding complications ...

Catheter-directed thrombolysis (CDT) is associated with a lower risk for death and major bleeding complications than systemic thrombolysis for patients with intermediate- or high-risk pulmonary ...

November 25, 2010 (New York, New York) — Updated results from a study published last year show that patients with massive pulmonary embolism (PE) treated with ultrasound-accelerated catheter-directed ...

Pain, swelling, itching, eczema and venous ulcers are characteristic signs of post-thrombotic syndrome, a condition developed by roughly half the patients who have experienced serious deep vein ...

A modified reperfusion protocol for intermediate-risk pulmonary embolism (PE) seemed to work without causing excessive bleeding in the small randomized CANARY trial. Use of conventional ...

Pulmonary embolism (PE), a life-threatening condition caused by blood clots in the lung, has long posed a significant risk to patients worldwide. However, a recent study published in the Canadian ...

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today that EKOS and their Netherlands distributor, AngioCare BV, are supporting a Dutch multicentre randomized trial (DUET) designed to ...

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation, a privately held medical device company located in Bothell, Washington, announced the results of DUET, the world’s first and only multi-center ...